Top News

GenAI-native autonomous medical coding startup Arintra has secured $21 Mn (about INR 184 Cr) in its Series A funding round led by Peak XV Partners.

The round also saw participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13 and other strategic investors.

The latest investment extends PeakXV’s earlier infusion into Arintra via its accelerator programme Surge.

Arintra plans to deploy the fresh proceeds to expand its presence across healthcare ecosystems and physician groups, ramping up product development, boosting its talent pool and setting up bay area headquarters to cater to surging demand.

Founded in 2020 by Nitesh Shroff and Preeti Bhargava, Arintra offers an AI-native autonomous medical coding platform that automates insurance claims submission. It claims to convert patient information into insurance claims with 96% accuracy and zero human intervention.

The startup claims to combine autonomous medical coding with clinical documentation improvement (CDI) and payer-aware denials insights in a single interface.

“By helping providers document what was done, code what was documented, and support what was charged, we enable them to secure full, compliant reimbursement at a lower cost, with fewer delays and far less manual effort,” said Bhargava.

Arintra’s fundraise adds to the larger story of India’s rapidly expanding GenAI landscape. Since 2020, the country’s native AI ventures have flourished, with over 140 startups raising more than $1.5 Bn in funding, reflecting a heightened innovation and investor confidence in the sector.

While SarvamAI and Krutrim focus on building Indic LLMs, others are using AI to provide personalised customer and operational assistance. Many more are adopting AI to boost user experience, automate processes and optimise decision-making across various sectors.

As per Inc42’s report titled India’s Generative AI Startup Landscape, 2023, the country’sGenAI market is expected to surpass $17 Bn by 2030 from $1.1 Bn in 2023, growing at a CAGR of 48%.

Meanwhile, investor sentiment toward Indian tech startups, especially in AI and advanced hardware, is on the rise, with many actively scouting opportunities in these domains. Over 57% of respondents are eyeing early stage AI ventures, while 22% are targeting growth stage AI or advanced hardware such as defence tech.

Fuelled by strong investor appetite and favourable policy support, AI and defence tech are poised to dominate India’s startup scene in the latter half of 2025.

The post Arintra Bags $21 Mn From Peak XV To Power AI Medical Coding appeared first on Inc42 Media.